First Results From Expanded Newborn Screening in slovak Republic

[1] Burgard P, Rupp K, Lindner M, Haege G, Rigter T, Weinreich SS, Loeber JG, Taruscio D, Vittozzi L, Cornel MC, Hofmann GF. Newborn screening programmes in Europe; arguments and eforts regarding harmonization. Part 2 - From screening laboratory results to treatment, follow-up and quality assurance. J Inherit Metab Dis. 2012;35: 613-25.10.1007/s10545-012-9484-z22544437Search in Google Scholar

[2] Dluholucký S, Knapková M, Záhorcová M. Newborn screening in Slovakia - from 1985 till today. Acta Fac Pharm Univ Comen 2013, Suppl.VIII:32-36 Available at http://www.degruyter.com/view/j/afpuc.2013.60.issue-supplementum8/afpuc-2013-0006/afpuc-2013-0006. xml, Accessed at February 28, 201410.2478/afpuc-2013-0006Search in Google Scholar

[3] Lam C, Carter JM, Cederbaum SD, Neidich J, Gallant NM, Lorey F, Feuchtbaum L, Wong DA. Analysis of cases of 3 – methylcrotonyl CoA carboxylase defciency (3-MCCD) in the California newborn screening program reported in the state database. Mol Genet Metab. 2013 (4): 477-83.10.1016/j.ymgme.2013.09.00624103308Search in Google Scholar

[4] Loeber JG1, Burgard P, Cornel MC, Rigter T, Weinreich SS, Rupp K, Hofmann GF, Vittozzi L. Newborn screening programmes in Europe; arguments and eforts regarding harmonization. Part 1 – From blood spot to screening result. J Inherit Metab Dis. 2012 Jul;35(4):603-11.10.1007/s10545-012-9483-022552820Search in Google Scholar

[5] Pollitt RJ. Introducing new screens: why are we all doing different things? J Inherit Metab Dis. 2007, 30(4):423-9.10.1007/s10545-007-0647-217616846Search in Google Scholar

[6] Schimmenti LA, Crombez EA, Schwahn BC, Heese BA, Wood TC, Schroer RJ. Bentler K, Cederbaum S, Sarafo-glou K, McCann M, Rinaldo P, Matern D, di San Filippo CA, Pasquali M, Berry SA, Longo N. Expanded screening iden-tifes maternal primary carnitine defciency. Mol Genet Metab. 2007, 90(4):441-5.10.1016/j.ymgme.2006.10.00317126586Search in Google Scholar

[7] Wilcken B, Wiley V, Sim KG, Carpenter K. Carnitine transporter defect diagnosed by newborn screening with electroscopy tandem mass spectrometry. J Pediatr. 2001:138(4):581-4.10.1067/mpd.2001.11181311295726Search in Google Scholar

[8] Wilcken B, Haas M, Joy P, Wiley V, Bowling F, Carpenter K, Christodoulou J, Cowley D, Ellaway C, Fletcher J, Kirk E P, Lewis B, McGill J, Peters H, Pitt J, Ranieri E, Yaplito-Lee J, Boneh A. Expanded newborn screening: outcome in screened and unscreened patients at age 6 years. Pediatrics 2009, 124(2):e241-e24810.1542/peds.2008-058619620191Search in Google Scholar

[9] Wilcken B Newborn screening: how are we traveling, and where should we be going. J Inherit Metab Dis. 2011, 34(3):569-74.10.1007/s10545-011-9326-421499716Search in Google Scholar

[10] Wilson JMG, Jungner G. Principles and practice of screening for disease Geneva: WHO; 1968. Available from: http:// www.who.int/bulletin/volumes/86/4/07-050112BP.pdf.Search in Google Scholar

[11] Zabransky S. Newborn screening for endocrine and metabolic diseases in Europe 2000. Screening J 2002, 2:1-14Search in Google Scholar

[12] Professional Guidance of the Ministry of health of the Slovak republic 42/2012 about screening (in Slovak) Available at: http://www.health.gov.sk/Zdroje?/Sources/do-kumenty/vestniky_mz_sr/2012/vestnik-39-60-2012.pdf Accessed at 1.3:2014Search in Google Scholar